Avantax Advisory Services’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.14M Buy
6,501
+567
+10% +$85.3K 0.01% 1087
2025
Q1
$798K Buy
5,934
+501
+9% +$66K ﹤0.01% 1206
2024
Q4
$686K Buy
5,433
+157
+3% +$23.3K ﹤0.01% 1249
2024
Q3
$877K Buy
+5,276
New +$798K 0.01% 1100

Other funds holding THC

Avantax Advisory Services's THC Position: Q2 2025 in Review

Avantax Advisory Services increased its Tenet Healthcare (THC) stake by 9.6% in Q2 2025, buying an estimated $85.3K and bringing the position to 6,501 shares worth $1.14M. The position accounts for 0.01% of the portfolio, ranked #1087.

Avantax Advisory Services first reported a position in THC in Q3 2024 and has held it in 4 quarters since. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

  • Avantax Advisory Services held 6,501 shares of Tenet Healthcare worth $1.14M as of Q2 2025.
  • Avantax Advisory Services bought 567 Tenet Healthcare shares in Q2 2025, an estimated $85.3K.
  • Tenet Healthcare made up 0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #1087 holding.
  • Avantax Advisory Services first reported a position in Tenet Healthcare in Q3 2024 and has held it in 4 quarters since.
  • 626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.